Formosa Laboratories, Inc. (TPE:4746)

Formosa Laboratories Revenue

Formosa Laboratories had revenue of 1.11B TWD in the quarter ending June 30, 2026, a decrease of -10.60%. This brings the company's total for the last twelve months to 4.64B, down -2.71% year-over-year. In the year 2025, Formosa Laboratories had annual revenue of 4.85B with 2.54% growth. That makes Formosa Laboratories the 19,963rd largest company in the world by revenue and 760th in Taiwan.

• Revenue (ttm): 4.64B
• Revenue Growth: -2.71%
• P/S Ratio: 1.22
• Revenue / Employee: 16.57M
• Employees: 280
• Market Cap: 5.68B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Active Pharmaceutical Ingredients(API) 4.84B 99.7%
• Other Operating Departments 16.96M 0.3%

By Geography

Chart

• Other 1.26B 25.9%
• United States 870.22M 17.9%
• India 755.05M 15.6%
• Netherlands 610.72M 12.6%
• China 441.13M 9.1%
• Taiwan 372.69M 7.7%
• Japan 280.40M 5.8%
• Germany 262.73M 5.4%

Fiscal year ended Dec 31, 2025 See the full Formosa Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.85B	120.31M	2.54%
Dec 31, 2024	4.73B	370.60M	8.50%
Dec 31, 2023	4.36B	594.94M	15.80%
Dec 31, 2022	3.77B	623.10M	19.83%
Dec 31, 2021	3.14B	66.95M	2.18%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error